文献速递眼底病与葡萄膜炎青光眼

Posner-Schlossman综合征欧洲研究组:多中心研究方案及基线患者特征

Posner-Schlossman Syndrome European Study Group: study protocol and baseline patients characteristics of a multicentre study.
PubMed 文献 · Br J Ophthalmol · 2024-11-22

PSS-ESG是一项回顾性多中心研究,旨在收集欧洲PSS患者的综合数据。共11个中心纳入107例患者(68男39女),93.4%为白人,葡萄膜炎发病年龄11-76岁(平均42±15岁)。80.3%患眼最佳矫正视力>0.5,44%患眼眼压>40 mmHg,78.5%患眼有角膜后沉着物,81例中50.6%房水PCR巨细胞病毒DNA阳性。

要点

  • PSS-ESG为欧洲首个针对PSS的多中心研究,纳入11个中心107例患者。
  • 基线特征:多数为中年白人男性,前房炎症轻,有角膜后沉着物,视力保留,眼压显著升高。
  • 81例房水PCR检测中50.6%巨细胞病毒DNA阳性。

核心结论

  • PSS-ESG是首个在非亚洲国家收集PSS患者综合数据的大型多中心研究。
  • PSS-ESG纳入的11个葡萄膜炎和青光眼中心中,典型PSS患者为中年白人男性,前房炎症轻,有角膜后沉着物,视力保留,眼压显著升高。

研究设计与样本

  • PSS-ESG为回顾性多中心研究,旨在评估PSS患者。
  • 研究由欧洲专家委员会设计并推动,包含三个数据集:基线、随访和眼压/青光眼数据集。
  • 共11个中心参与,纳入107例患者(68男,39女),93.4%为白人。

主要发现

  • 葡萄膜炎发病时患者年龄范围为11至76岁(平均42±15岁)。
  • 80.3%的患眼最佳矫正视力>0.5。
  • 44%的患眼眼压>40 mmHg。
  • 78.5%的患眼可见角膜后沉着物。
  • 56%和53%的病例前房未检测到闪辉或细胞。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The aim of the Posner-Schlossman Syndrome European Study Group (PSS-ESG) is to acquire a comprehensive dataset of European patients with PSS. Here, we present the first report on the study protocol and the clinical findings of the patients at baseline. METHODS: The PSS-ESG is a retrospective, multicentre study designed to evaluate patients with PSS. The study, designed and driven by a European Expert Committee includes three datasets: (1) the baseline, (2) the follow-up and (3) the intraocular pressure (IOP)/glaucoma dataset. RESULTS: A total of 11 centres adhered to the PSS-ESG and 107 patients were included (68 males, 39 females) mostly Caucasian (93.4%). At uveitis onset, the patient's age ranged between 11 and 76 years, (mean age: 42±15 years).Best-corrected visual acuity was >0.5 in 80.3% of the eyes, IOP was >40 mm Hg in 44% of the eyes. Keratic precipitates were found in 78.5% of the eyes. No flare or cells in anterior chamber were detected in 56% and 53% of the cases, respectively. PCR analysis on aqueous sample was positive for cytomegalovirus-DNA in 50.6% out of the 81 tested patients. CONCLUSIONS: The PSS-ESG is the first multicentre study aimed to collect a comprehensive dataset of patients with PSS in non-Asian countries. A middlde-aged Caucasian male with a low-grade anterior chamber inflammation, keratic precipitates, preserved visual acuity and marked increased in IOP seemed to be the standard PSS patient across the 11 uveitis and glaucoma centres participating in the PSS-ESG.

来源:Br J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Interlandi E, Cimino L, Accorinti M, et al. Posner-Schlossman Syndrome European Study Group: study protocol and baseline patients characteristics of a multicentre study. Br J Ophthalmol. 2024. PMID: 38811053. doi:10.1136/bjo-2023-324900

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。